Ke Huang
Nanjing, 210004, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
LncRNA IDH1-AS1 sponges miR-518c-5p to suppress proliferation of epithelial ovarian cancer cell by targeting RMB47.
Journal: Journal of biomedical research
Published: November 19, 2023
Tripartite-motif 3 represses ovarian cancer progression by downregulating lactate dehydrogenase A and inhibiting AKT signaling.
Journal: Molecular and cellular biochemistry
Published: July 16, 2023
LncRNA SLC25A21-AS1 increases the chemosensitivity and inhibits the progression of ovarian cancer by upregulating the expression of KCNK4.
Journal: Functional & integrative genomics
Published: January 18, 2023
Combined use of CA125, neutrophil/lymphocyte ratio and platelet/lymphocyte ratio for the diagnosis of borderline and malignant epithelial ovarian tumors.
Journal: Journal of ovarian research
Published: October 21, 2022
Long noncoding RNA RFPL1S-202 inhibits ovarian cancer progression by downregulating the IFN-β/STAT1 signaling.
Journal: Experimental cell research
Published: April 28, 2022
Peptide PDHPS1 Inhibits Ovarian Cancer Growth through Disrupting YAP Signaling.
Journal: Molecular cancer therapeutics
Published: October 19, 2021
Long Noncoding RNA CTD-2589M5.4 Inhibits Ovarian Cancer Cell Proliferation, Migration, and Invasion Via Downregulation of the Extracellular Matrix-Receptor Interaction Pathway.
Journal: Cancer biotherapy & radiopharmaceuticals
Published: July 09, 2021
Peptidome characterization of ovarian cancer serum and the identification of tumor suppressive peptide ZYX36-58.
Journal: Annals of translational medicine
Published: September 21, 2020
Showing 1-8 of 8
Last Updated: 09/26/2026